TrialOncotarget2016
Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma.
Lu Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
TrialOncotarget2016
Lu Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.